Fathy I. Abd Allah

Fathy I. Abd Allah

Auto-generated profile, based on publicly available information

Fathy I. Abd Allah

Department of Pharmaceutics and Industrial Pharmacy, Faculty of Pharmacy, Al-Azhar University, Cairo, Egypt

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2016 in International Journal of Pharmaceutics
Verified
Journal Article
Closed access
AAAhmed Al-Abd
Ahmed Al-Abd
Khalid M El-SayKhalid M El-Say
Khalid M El-Say
BABader M. Aljaeid
Bader M. Aljaeid
UFUsama Fahmy
Usama Fahmy
FAFathy I. Abd-Allah
Fathy I. Abd-Allah

1 January 2017 in Journal of Pharmaceutical Sciences
Verified
Journal Article
Closed access
MKMohammed A. Kassem
Mohammed A. Kassem
HEHossam Samir El-Sawy
Hossam Samir El-Sawy
FAFathy I. Abd-Allah
Fathy I. Abd-Allah
TATamer M. Abdelghany
Tamer M. Abdelghany
Khalid M El-SayKhalid M El-Say
Khalid M El-Say

26 March 2015 in Journal of Liposome Research
Verified
Journal Article
Closed access
Khalid M El-SayKhalid M El-Say
Khalid M El-Say
FAFathy I. Abd-Allah
Fathy I. Abd-Allah
ALAhmed E. Lila
Ahmed E. Lila
AHAbd El-Saboor A. Hassan
Abd El-Saboor A. Hassan
AKAlaa Eldin A. Kassem
Alaa Eldin A. Kassem
The purpose of this study was to load diacerein (DCR) in niosomes by applying response surface methodology and incorporate these niosomes in gel base for topical delivery. Box-Behnken design was used to investigate the effect of charge-inducing agent (X1), surfactant HLB (X2) and sonication time (X3) on the vesicle size (Y1), entrapment efficiency (Y2) and cumulative drug released (Y3). DCR niosomal formulations were prepared by thin film hydration method. The optimized formula was incorporated in different gel bases. DCR niosomal gels were evaluated for homogeneity, rheological behavior; in vitro release and pharmacodynamic activity by carrageenan-induced hind paw edema method in the rat compared with DCR commercial gel. The results revealed that the mean vesicle sizes of the prepared niosomes ranged from 7.33 to 23.72 µm and the entrapment efficiency ranged from 9.52% to 58.43% with controlled release pattern over 8 h. DCR niosomal gels exhibited pseudoplastic flow with thixotropic behavior. The pharmacodynamic activity of DCR niosomal gel in 3% HPMC showed significant, 37.66%, maximum inhibition of edema size in comparison with 20.83% for the commercial gel (p < 0.05). These results recommended the incorporation of DCR niosomes in 3% HPMC for topical application as a potent anti-inflammatory drug for the treatment of osteoarthritis.

1 September 2017 in Journal of Pharmaceutical Sciences
Verified
Journal Article
Closed access
Khalid M El-SayKhalid M El-Say
Khalid M El-Say
AAAhmed Al-Abd
Ahmed Al-Abd
OAOsama Ahmed
Osama Ahmed
KHKhaled M. Hosny
Khaled M. Hosny
FAFathy I. Abd-Allah
Fathy I. Abd-Allah

31 October 2018 in Drug Development and Industrial Pharmacy
Verified
Journal Article
Closed access
MAMohamed A. Akl
Mohamed A. Akl
HIHatem R. Ismael
Hatem R. Ismael
FAFathy I. Abd Allah
Fathy I. Abd Allah
AKAlla A. Kassem
Alla A. Kassem
ASAhmed M. Samy
Ahmed M. Samy
Tolmetin sodium (TS) is a non-steroidal anti-inflammatory drug (NSAID) indicated for treatment of musculoskeletal issues. As other NSAID, TS displays a marked side effects on the gastro-intestinal (GI) tract after oral administration. Tradational solid suppositories can cause pain and discomfort for patients, may reach the end of the colon; consequently, the drug can undergo the first-pass effect. TS liquid suppository (TS-LS) was developed to enhance patient compliance and rectal mucosal safety in high-risk patients receiving highly NSAID therapy. This work was conducted to optimize and evaluate Poloxamer P407/P188-based thermoresponsive TS-LS by using mucoadhesive polymers such as methylcellulose (MC). TS-LS was prepared by cold method and characterized their in-vitro physicochemical properties as gelation temperature (GT), gel strength, bioadhesive properties and in-vitro release. The safety of the prepared suppository on rectum, stomach and liver was evaluated histologically. Pharmacokinetic analyses were performed to compare rectal TS-LS to orally Rhumtol® capsules. The results showed that the optimized TS-LS; composed of P407/P188/MC (21/9/0.5% w/w) displayed gelation at rectum temperature ∼ 32.90°C, gel strength of 21.35 sec and rectal retention force at the administration site of 24.25 x 102 dyne/cm2. Moreover, TS-LS did not cause any morphological damage to the rectal tissues. Pharmacokinetic parameters of optimized TS-LS formulation revealed 4.6 fold increase in bioavailability as compared to Rhumtol® capsules. Taken together, the results demonstrated that liquid suppository is a potential and physically safe rectal delivery carrier for improvement rectal bioavailability and in vivo safety of TS.

22 February 2018 in AAPS PharmSciTech
Verified
Journal Article
Closed access
PDF file
MKMohammed A. Kassem
Mohammed A. Kassem
MMMohamed Adel Megahed
Mohamed Adel Megahed
SESherif K. Abu Elyazid
Sherif K. Abu Elyazid
FAFathy I. Abd-Allah
Fathy I. Abd-Allah
TATamer M. Abdelghany
Tamer M. Abdelghany
Khalid M El-SayKhalid M El-Say
Khalid M El-Say